Emerging Role of Cannabis Compounds in Fatty Liver Disease
Emerging research shows cannabis compounds metabolic pathways may modulate metabolic-associated fatty liver disease (MASLD). This condition affects millions with limited treatment options. Understanding these pathways is crucial for clinicians monitoring…
Daily Digest: Last 2 Hours: Stroke Risk, Industry Maturation, and Reassurance for Older Adults — March 09, 2026
A synthesis of 9 recently added cannabis articles — key themes, clinical context, and Dr. Caplan's take.
Study: Cannabis Use Among Older Adults Does Not Accelerate Mental Decline
This study on cannabis use and cognitive safety in older adults found no evidence of accelerated mental decline. The findings challenge previous assumptions about cannabis and aging cognition. This evidence supports individualized clinical assessments…
Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving Metabolic Health
Recent research highlights cannabidiol CBD liver health benefits, showing promise in reducing liver fat and improving metabolic markers. These findings suggest potential therapeutic roles for CBD and CBG in fatty liver disease. While preliminary, this…
Daily Digest: Cannabinoids and Liver Disease Lead a Busy News Cycle — March 07, 2026
This cycle highlights cognitive safety in older adults cannabis use as a key research focus. Emerging clinical evidence complements findings on cannabinoids and fatty liver disease. State-level cannabis policy developments also impact patient access and…
Study reveals cannabis compounds reduce threat of fatty liver disease | Health – WFMZ.com
Emerging research shows cannabis compounds reduce fatty liver disease by improving insulin sensitivity and reducing liver fat. These cannabinoids exhibit genuine metabolic effects that may benefit older patients. While promising, further clinical trials…
Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health
Metabolic-associated fatty liver disease is a growing concern worldwide. Research suggests that cannabis compounds CBD and CBG may reduce liver fat and improve metabolic markers. These findings highlight potential adjunctive therapies for metabolic…
Daily Digest: Last 7 Hours: Cannabis, Liver Disease, and the Policy Gaps That Still Haunt Patients — March 07, 2026
This digest highlights policy regulation cannabis patient access challenges that persist despite legalization. Patients face barriers due to regulatory gaps that limit real access. Understanding these issues is crucial for clinicians and patients alike.
Daily Digest: Cannabinoids and Fatty Liver Disease Promise Amid Regulatory Gaps — March 06, 2026
This digest reviews cannabinoids and liver disease research with a focus on emerging preclinical evidence for fatty liver disease. The research highlights promising mechanisms but also regulatory gaps. Clinicians remain cautious pending robust clinical…
Cannabis Compounds Exhibit Potential in Combatting Fatty Liver Disease
Emerging cannabis compounds fatty liver disease research suggests potential metabolic benefits in reducing hepatic steatosis. This early-stage evidence highlights therapeutic possibilities beyond lifestyle changes. Further human trials are needed to…